Conclusive decision making with our diagnostic kinome activity technology

Our mission is to support oncologists, clinicians and researchers in making conclusive decisions resulting in first time right patient treatment in cancer research. We developed a multiplex kinome activity profiling technology based on next generation kinase science and 15 years of experience to make this possible.

The IOpener™, our diagnostic blood test, provides rapid and non-invasive measurement of real-time cellular kinome activity. Kinases play a crucial role in immune checkpoint regulation and therefore predict patient response before immunotherapy has started. Response or non-response is driven by an individual patient’s kinase profile. Matching the kinase profile to the best therapeutic can dramatically improve patient outcomes and increase survival.

Diagnostic Blood Test
Pharma & Biotech
Research & Scientists

The IOpener™, our diagnostic blood test, provides rapid and non-invasive measurement of real-time cellular kinome activity.

Read more

Discovering, analyzing and optimizing therapeutic candidates and their mechanisms of action based on our comprehensive and robust kinase technology providing insights in real-time cell signaling

Read more

New data and publishable insights on kinase signaling, target interaction and pathway elucidation for biomarker and target discovery

Read more
27-03-2019
ISO Accreditation for the Diagnostic Assay Services Lab
28-01-2019
PamGene's NHR platform in major EDCMET Consortium
06-06-2018
At ASCO 2018: Predictive biomarkers for immunotherapy in Mel...
20-04-2018
AACR 2018 follow-up
19-03-2018
Society of Toxicology Meeting: Nuclear Receptor Applications